Clinical Trials Directory

Trials / Completed

CompletedNCT01683916

Anesthetic Requirement and Stress Hormone Response During Surgery in Spinal Cord-injured Patients

Chonnam National University Hospital IRB

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
Chonnam National University Hospital · Academic / Other
Sex
All
Age
10 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Spinal cord injury (SCI) reduces anesthetic requirements and stress hormonal responses. Anesthetic requirements and stress hormone response are compared in SCI patients undergoing anesthesia with sevoflurane supplemented with clinically equivalent doses of either N2O or remifentanil.

Detailed description

Nitrous oxide (N2O) is often used for anesthetic adjuvant, but may be associated with side effects and toxicities. Remifentanil shares characteristics with N2O, including anesthetic-reducing and antinociceptive effects and a rapid recovery. Anesthetic requirements and stress hormone response in SCI patients undergoing anesthesia with sevoflurane supplemented with clinically equivalent doses of either N2O or remifentanil. Forty-five SCI patients scheduled to undergo pressor sore surgery below the level of the injury are randomly allocated to receive either sevoflurane alone (control, n=15), or combined with 67% N2O (n=15) or target-controlled infusions of 1.37 ng/mL remifentanil (n=15). Sevoflurane concentration is titrated to maintain a Bispectral Index (BIS) value of 40-50. Measurements include end-tidal sevoflurane concentrations, mean arterial blood pressure (MAP), heart rate (HR), and plasma catecholamine and cortisol concentrations.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-09-12
Last updated
2017-07-21

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01683916. Inclusion in this directory is not an endorsement.